Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Fractyl Health Inc (NASDAQ: GUTS) was $1.00 for the day, down -6.55% from the previous closing price of $1.07. In other words, the price has decreased by -$6.55 from its previous closing price. On the day, 0.59 million shares were traded. GUTS stock price reached its highest trading level at $1.09 during the session, while it also had its lowest trading level at $0.9751.
Ratios:
Our analysis of GUTS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.63 and its Current Ratio is at 3.63. In the meantime, Its Debt-to-Equity ratio is 2.20 whereas as Long-Term Debt/Eq ratio is at 2.02.
On February 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $18.
On February 27, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $26.BofA Securities initiated its Buy rating on February 27, 2024, with a $26 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 14 ’25 when Royan Ajay bought 17,901 shares for $1.28 per share. The transaction valued at 22,980 led to the insider holds 17,901 shares of the business.
Barnes Kelly Ann bought 31,000 shares of GUTS for $40,210 on Mar 14 ’25. The Director now owns 31,000 shares after completing the transaction at $1.30 per share. On Mar 13 ’25, another insider, SCHULMAN AMY W, who serves as the Director of the company, bought 8,550 shares for $1.17 each. As a result, the insider paid 9,964 and bolstered with 8,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 48915308 and an Enterprise Value of 49826648. For the stock, the TTM Price-to-Sale (P/S) ratio is 543.46 while its Price-to-Book (P/B) ratio in mrq is 1.72. Its current Enterprise Value per Revenue stands at 535.77 whereas that against EBITDA is -0.537.
Stock Price History:
The Beta on a monthly basis for GUTS is 0.03, which has changed by -0.8542274 over the last 52 weeks, in comparison to a change of 0.049593568 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $7.89, while it has fallen to a 52-week low of $1.01. The 50-Day Moving Average of the stock is -28.81%, while the 200-Day Moving Average is calculated to be -58.63%.
Shares Statistics:
GUTS traded an average of 298.61K shares per day over the past three months and 286320 shares per day over the past ten days. A total of 48.76M shares are outstanding, with a floating share count of 20.86M. Insiders hold about 57.37% of the company’s shares, while institutions hold 34.81% stake in the company. Shares short for GUTS as of 1741910400 were 3015874 with a Short Ratio of 10.10, compared to 1739491200 on 3098790. Therefore, it implies a Short% of Shares Outstanding of 3015874 and a Short% of Float of 11.92.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
